MAXCYTE, INC.
Company Stats
- Market Cap
- $115.6M
- as of Sep 30, 2026
- Shares Outstanding
- 103.2M
- Free Float
- 89.9%
Income Statement
- Revenue
- $33.0M
- Operating Income
- -$51.9M
- Net Income
- -$44.6M
- EBITDA
- -$47.6M
- Non-cash Impairment
- $3.6M
- Revenue Growth, 3Y
- -9.3%
- FCF Margin, 3Y Avg
- -82.3%
- FCF Margin, Worst Year
- -109.5%
Cash Flow
- Free Cash Flow
- -$36.2M
- FCF Yield
- -31.3%
- Owner FCF Yield
- -39.3%
Balance Sheet
- Cash & Equivalents
- $20.1M
Returns & Capital
- SBC, 3Y Avg
- $12.1M
Cash Flow by Year
| Year | Revenue | FCF | Margin |
|---|---|---|---|
| FY2025 | $33.0M | -$36.2M | -109.5% |
| FY2024 | $38.6M | -$29.3M | -75.8% |
| FY2023 | $41.3M | -$25.4M | -61.5% |
| FY2022 | $44.3M | -$33.3M | -75.1% |
| FY2021 | $33.9M | -$14.5M | -42.8% |
Annual filing data through FY ended December 31, 2025; shares and float as of October 28, 2026. Yields and enterprise value use the calculated market cap above, at its as-of date. Ratios are our calculations from reported figures.
Micro-Cap Earnings Roundup for Week of Oct. 12, 2026
Stronger demand supports expansion as pricing diverges